A 28-week gestational age male infant is born at 1,050g (2 lbs and 5 oz) via emergent cesarean section due to placental abruption. His neonatal course is complicated by respiratory distress syndrome requiring supplemental oxygen, two episodes of late-onset sepsis, and poor weight gain. He is now 3 weeks old and remains in the NICU on 0.5L nasal cannula oxygen. Vital signs are stable.
The neonatology team contacts you to schedule his first ophthalmology screening for retinopathy of prematurity. When should this infant's first dilated fundus examination be performed?
A) Now, at 3 weeks postnatal age (31 weeks postmenstrual age)
B) At 4 weeks postnatal age (32 weeks postmenstrual age)
C) At 36 weeks postmenstrual age
D) When the infant is medically stable and off supplemental oxygen
E) At 40 weeks postmenstrual age (term equivalent)
The correct answer is B.
The optimal timing for this infant's first ROP screening exam is 4 weeks postnatal age, which corresponds to 32 weeks postmenstrual age. Per joint AAP/AAO/AAPOS guidelines, the first dilated fundus examination should be scheduled at 4 weeks postnatal age OR 31 weeks postmenstrual age, whichever is later. All infants born at ≤30 weeks gestational age or with a birth weight ≤1,500 g meet criteria for screening, and this infant satisfies both.
For this infant born at 28 weeks gestational age:
Since 4 weeks postnatal (32 weeks postmenstrual age) comes later than 31 weeks postmenstrual age (3 weeks postnatal), the exam should be scheduled at 4 weeks postnatal age. The "whichever is later" rule ensures the retina has reached a stage of vascular development at which pathologic ROP changes are reliably detectable, while avoiding unnecessary stress to a critically ill neonate from a premature examination.
(A) Examining the infant now at 3 weeks postnatal age (31 weeks postmenstrual age) satisfies one criterion of the guideline but not both. Since 4 weeks postnatal age has not yet been reached, the exam would be premature. Choosing the earlier of the two criteria is a common error made when interpreting this guideline and risks missing pathology that has not yet manifested.
(C) Waiting until 36 weeks postmenstrual age is too late and poses a risk for irreversible vision loss. Treatable Type 1 ROP can develop well before this point, and guidelines recommend treatment within 48-72 hours of diagnosis to prevent progression to retinal detachment. (D) Systemic illness and ongoing supplemental oxygen use are not reasons to postpone screening for ROP. These are risk factors for ROP development and progression and would make timely examination even more urgent.
(E) Waiting until 40 weeks postmenstrual age (term equivalent) is too late since untreated ROP could have already progressed to tractional retinal detachment. Visual prognosis is significantly worse at this stage, even with surgical intervention.
Sources:
Kaur K, Mikes BA. Retinopathy of Prematurity. [Updated 2025 Jun 2]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK562319/
Reynolds JD, Dobson V, Quinn GE, Fielder AR, Palmer EA, Saunders RA, Hardy RJ, Phelps DL, Baker JD, Trese MT, Schaffer D, Tung B; CRYO-ROP and LIGHT-ROP Cooperative Study Groups. Evidence-based screening criteria for retinopathy of prematurity: natural history data from the CRYO-ROP and LIGHT-ROP studies. Arch Ophthalmol. 2002 Nov;120(11):1470-6. doi: 10.1001/archopht.120.11.1470. PMID: 12427059.